Cargando…

Re: Silke Gillessen Sommer, Thomas Powles. Advice for Medical Oncology Care of Urological Cancer Patients During the COVID-19 Pandemic. Eur Urol 2020;78:e2–3: Is It Always Correct to Continue Androgen Receptor Signaling Inhibitors in the COVID-19 Era?

Detalles Bibliográficos
Autor principal: Di Lorenzo, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association of Urology. Published by Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180375/
https://www.ncbi.nlm.nih.gov/pubmed/32349931
http://dx.doi.org/10.1016/j.eururo.2020.04.030
_version_ 1783525807386263552
author Di Lorenzo, Giuseppe
author_facet Di Lorenzo, Giuseppe
author_sort Di Lorenzo, Giuseppe
collection PubMed
description
format Online
Article
Text
id pubmed-7180375
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Association of Urology. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71803752020-04-24 Re: Silke Gillessen Sommer, Thomas Powles. Advice for Medical Oncology Care of Urological Cancer Patients During the COVID-19 Pandemic. Eur Urol 2020;78:e2–3: Is It Always Correct to Continue Androgen Receptor Signaling Inhibitors in the COVID-19 Era? Di Lorenzo, Giuseppe Eur Urol Article European Association of Urology. Published by Elsevier B.V. 2020-07 2020-04-24 /pmc/articles/PMC7180375/ /pubmed/32349931 http://dx.doi.org/10.1016/j.eururo.2020.04.030 Text en © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Di Lorenzo, Giuseppe
Re: Silke Gillessen Sommer, Thomas Powles. Advice for Medical Oncology Care of Urological Cancer Patients During the COVID-19 Pandemic. Eur Urol 2020;78:e2–3: Is It Always Correct to Continue Androgen Receptor Signaling Inhibitors in the COVID-19 Era?
title Re: Silke Gillessen Sommer, Thomas Powles. Advice for Medical Oncology Care of Urological Cancer Patients During the COVID-19 Pandemic. Eur Urol 2020;78:e2–3: Is It Always Correct to Continue Androgen Receptor Signaling Inhibitors in the COVID-19 Era?
title_full Re: Silke Gillessen Sommer, Thomas Powles. Advice for Medical Oncology Care of Urological Cancer Patients During the COVID-19 Pandemic. Eur Urol 2020;78:e2–3: Is It Always Correct to Continue Androgen Receptor Signaling Inhibitors in the COVID-19 Era?
title_fullStr Re: Silke Gillessen Sommer, Thomas Powles. Advice for Medical Oncology Care of Urological Cancer Patients During the COVID-19 Pandemic. Eur Urol 2020;78:e2–3: Is It Always Correct to Continue Androgen Receptor Signaling Inhibitors in the COVID-19 Era?
title_full_unstemmed Re: Silke Gillessen Sommer, Thomas Powles. Advice for Medical Oncology Care of Urological Cancer Patients During the COVID-19 Pandemic. Eur Urol 2020;78:e2–3: Is It Always Correct to Continue Androgen Receptor Signaling Inhibitors in the COVID-19 Era?
title_short Re: Silke Gillessen Sommer, Thomas Powles. Advice for Medical Oncology Care of Urological Cancer Patients During the COVID-19 Pandemic. Eur Urol 2020;78:e2–3: Is It Always Correct to Continue Androgen Receptor Signaling Inhibitors in the COVID-19 Era?
title_sort re: silke gillessen sommer, thomas powles. advice for medical oncology care of urological cancer patients during the covid-19 pandemic. eur urol 2020;78:e2–3: is it always correct to continue androgen receptor signaling inhibitors in the covid-19 era?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180375/
https://www.ncbi.nlm.nih.gov/pubmed/32349931
http://dx.doi.org/10.1016/j.eururo.2020.04.030
work_keys_str_mv AT dilorenzogiuseppe resilkegillessensommerthomaspowlesadviceformedicaloncologycareofurologicalcancerpatientsduringthecovid19pandemiceururol202078e23isitalwayscorrecttocontinueandrogenreceptorsignalinginhibitorsinthecovid19era